Cardiopulmonary Exercise Testing and Preoperative Risk Stratification

May 20, 2014 updated by: Mike Grocott, University College London Hospitals

A Randomised Controlled Trial of the Utility of Cardiopulmonary Exercise (CPX) Testing for Preoperative Risk Stratification to Guide Perioperative Care and Thereby Reduce Postoperative Morbidity

The investigators would like to evaluate the use of cardiopulmonary exercise tests (CPX) in guiding the care pathway of patients undergoing colorectal operations. In the intervention group care will be guided by CPX results and in the control group care will be guided by the doctors assessment. The investigators would like to assess the impact of this on patient outcome, patient satisfaction and resource usage.

Study Overview

Detailed Description

Each year 20000 UK patients die within 30 days of surgery. It seems that in the UK a patient's chances of becoming seriously unwell or dying following surgery is higher than in comparable countries. Fewer beds in the UK are given over to Intensive Care than in these other countries. Closer attention to the care given after operations, which can be achieved on intensive care units (ICU), almost certainly reduces the chances of serious illness following major surgery. An increase in the number of intensive care unit beds in the UK is extremely unlikely. Better use of the available intensive care beds could be achieved by allocating them where they are believed to improve outcome (following surgery) and by allocating them to patients most likely to benefit.

Tests used to assess risk of surgery to patients are largely ineffective. Cardiopulmonary exercise tests (CPX) seem to be effective at identifying patients at risk of death or serious illness post surgery. This information has been used in studies to select patients for ICU beds and reduce deaths. The studies so far have limitations in their design and scope which means we can't be certain this approach works in the UK.

We suggest a study to answer this question more conclusively and more specifically in UK patients. We will randomly divide patients between two groups. In the 1st group choice of postoperative care environment is based on best current practice and in the other group we will make these decisions (critical care or ward) based on the results of the CPX.

We hope that the benefits will include less patients becoming seriously ill or dying and shorter stays in hospital after surgery following major operations. We also hope the information will help patients understand the risks of their operation better and therefore make better informed decisions. This may also reduce the overall cost of surgery for hospitals.

Study Type

Interventional

Enrollment (Actual)

228

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • London, United Kingdom, NW1 2BU
        • University College London Hospitals Nhs Foundation Trust
      • London, United Kingdom, N19 5NF
        • Whittington Hospital NHS Trust
      • Southampton, United Kingdom
        • Southampton University Hospitals NHS Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Adults ≥ 18 years age
  2. Males
  3. Females
  4. Listed for elective(non-emergency) colorectal surgery

Exclusion Criteria:

  1. Age < 18 years age
  2. Patient unwilling/unable to consent
  3. Adults with learning disabilities or dementia
  4. Prisoners
  5. Any contraindication to cardiopulmonary exercise testing (as outlined by *American Association of Anaesthesia:

    • Acute MI (3-5 days)
    • Unstable angina
    • Uncontrolled arrhythmias
    • Syncope
    • Acute endocarditis
    • Acute myocarditis
    • Acute pericarditis
    • Symptomatic severe aortic stenosis
    • Uncontrolled heart failure
    • Acute pulmonary embolism or infarction
    • Thrombosis of lower extremities
    • Dissecting aneurysm
    • Uncontrolled asthma
    • Pulmonary oedema
    • Room air desaturation at rest <85%
    • Respiratory failure
    • Acute non-cardiopulmonary disorder that may affect exercise performance or be aggravated by exercise Mental impairment leading to inability to co-operate
  6. Patients already enrolled in an interventional study
  7. Previous CPX test result recorded in the medical notes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: A
Control - Standard Perioperative Pathway, clinician decides post-operative care environment (usual care)
  • AT > 11ml/min/kg no myocardial ischaemia or Ve/VO2 <35 - Level 1 Ward Care
  • AT > 11ml/min/kg with myocardial ischaemia or Ve/VO2 >35 - Level 2/3 (ITU) Critical Care Unit
  • AT <11mls/min/kg - Level 2/3 Critical Care Unit
  • AT <8mls/min/kg - Level 2/3 Critical Care Unit/ consider cancellation or alternative procedure
Experimental: B
Intervention - Perioperative care pathway guided by CPX Results i.e.anaerobic threshold & ventilatory equivalents
  • AT > 11ml/min/kg no myocardial ischaemia or Ve/VO2 <35 - Level 1 Ward Care
  • AT > 11ml/min/kg with myocardial ischaemia or Ve/VO2 >35 - Level 2/3 (ITU) Critical Care Unit
  • AT <11mls/min/kg - Level 2/3 Critical Care Unit
  • AT <8mls/min/kg - Level 2/3 Critical Care Unit/ consider cancellation or alternative procedure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Postoperative morbidity (presence or absence of POMS defined morbidity)
Time Frame: Day 5
Day 5

Secondary Outcome Measures

Outcome Measure
Time Frame
Post operative morbidity domains e.g. gastrointestinal, renal, pulmonary
Time Frame: Day 5
Day 5
Total postoperative ITU bed utilisation
Time Frame: End of hospital stay i.e. day of hospital discharge
End of hospital stay i.e. day of hospital discharge
Total postoperative bed utilisation
Time Frame: End of hospital stay i.e. day of hospital discharge
End of hospital stay i.e. day of hospital discharge
ITU re-admission
Time Frame: End of hospital stay i.e. day of hospital discharge
End of hospital stay i.e. day of hospital discharge
Death
Time Frame: Should death occur
Should death occur
SF36 (compared with SF36 at baseline)
Time Frame: 12 months post day of surgery
12 months post day of surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Michael PW Grocott, University College, London
  • Principal Investigator: Paula Meale, University College, London
  • Principal Investigator: Michael Mythen, University College, London
  • Principal Investigator: Ayo Oshowo, Whittington Hospital NHS Trust
  • Principal Investigator: Mervyn Singer, University College, London
  • Principal Investigator: Geoff Bellingan, University College London Hospitals
  • Principal Investigator: Kay Mitchell, University College, London
  • Principal Investigator: Hasan Muktar, The Whittington Hospital Hospital NHS Trust
  • Principal Investigator: Alistair Windsor, University College London Hospitals
  • Principal Investigator: Jim Down, University College London Hospitals
  • Principal Investigator: Martin B Kuper, Whittington Hospital NHS Trust
  • Principal Investigator: Denny ZH Levett, University College, London
  • Principal Investigator: Phil Hennis, PhD, UCL
  • Principal Investigator: Alasdair O'Doherty, MSc, UCL
  • Principal Investigator: Alec Engledow, UCLH
  • Principal Investigator: Aundrea Mulreany, Whittington Hospital
  • Principal Investigator: Carolyn Dr Way, University Hospital Southampton NHS Foundation Trust
  • Principal Investigator: Karen Linford, University Hospital Southampton NHS Foundation Trust
  • Principal Investigator: Clare Bolger, University Hospital Southampton NHS Foundation Trust
  • Principal Investigator: Paul Nichols, University Hospital Southampton NHS Foundation Trust
  • Principal Investigator: Kim Golder, University Hospital Southampton NHS Foundation Trust
  • Principal Investigator: John S Knight, University Hospital Southampton NHS Foundation Trust
  • Principal Investigator: Michael Celinski, University Hospital Southampton NHS Foundation Trust
  • Principal Investigator: Grace Adesina, University College London Hospitals

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2008

Primary Completion (Actual)

June 1, 2013

Study Completion (Actual)

May 1, 2014

Study Registration Dates

First Submitted

August 18, 2008

First Submitted That Met QC Criteria

August 19, 2008

First Posted (Estimate)

August 20, 2008

Study Record Updates

Last Update Posted (Estimate)

May 21, 2014

Last Update Submitted That Met QC Criteria

May 20, 2014

Last Verified

May 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • 07/0114
  • 07/H0716/55 (Other Identifier: NHNN REC Number)
  • PB-PG-0906-11426 (Other Grant/Funding Number: UK National Institute of Health Research (NIHR))

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on Perioperative care pathway guided by CPX results

3
Subscribe